ASC30

ASC30 · Ascletis Pharma (China) Co., Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASC30, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus [Phase 2]

See pricing